![Bryan Fedorak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Bryan Fedorak is the founder of Bartesian, Inc. He is currently working as a Director at Metabolomic Technologies, Inc.
Actieve functies van Bryan Fedorak
Bedrijven | Functie | Begin |
---|---|---|
Bartesian, Inc.
![]() Bartesian, Inc. Industrial MachineryProducer Manufacturing Bartesian, Inc. engages in the creation of cocktail drinks business. It offers capsule drink-maker such as vodka, rum, tequila, margarita, and gin. The company was founded by Bryan Fedorak and Ryan Close and is headquartered in Kitchener, Canada. | Oprichter | - |
Metabolomic Technologies, Inc.
![]() Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Bartesian, Inc.
![]() Bartesian, Inc. Industrial MachineryProducer Manufacturing Bartesian, Inc. engages in the creation of cocktail drinks business. It offers capsule drink-maker such as vodka, rum, tequila, margarita, and gin. The company was founded by Bryan Fedorak and Ryan Close and is headquartered in Kitchener, Canada. | Producer Manufacturing |
Metabolomic Technologies, Inc.
![]() Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Commercial Services |